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Abstract
The specific membrane capacitance and conductivity of mammalian cells, which reflect their surface morphological complexities and
membrane barrier functions, respectively, have been shown to respond to cell physiologic and pathologic changes. Here, the effects of
induced apoptosis on these membrane properties of cultured human promyelocytic HL-60 cells are reported. Changes in membrane
capacitance and conductivity were deduced from measurements of cellular dielectrophoretic crossover frequencies following treatment with
genistein (GEN). The apparent specific cell membrane capacitance of HL-60 cells fell from an initial value of 17.6F0.9 to 9.1F0.5 mF/m2 4
h after treatment. Changes began within minutes of treatment and preceded both the externalization of phosphatidylserine (PS), as gauged by
the Annexin V assay, and the appearance of a sub-G1 cell subpopulation, as determined through ethidium bromide staining of DNA.
Treatment by the broad spectrum caspase inhibitor N-benzyloxycarbony-Val-Ala-Asp(O-methyl)-fluoromethyketone (zVAD-fmk) did not
prevent these early cell membrane dielectric responses, suggesting that the caspase system was not involved. Although membrane
conductivity did not alter during the first 4 h of GEN treatment, it rose significantly and progressively thereafter. Finally, as the barrier
function failed and the cells became necrotic, it increased by many orders of magnitude. The effective membrane capacitance and
conductivity findings serve to focus attention on the membrane as a site for early participation in apoptosis. In conjunction with our prior
reports of the use of dielectric methods for cell manipulation and separation, these results demonstrate that dielectrophoretic technologies
should be applicable to the rapid detection, separation, and quantification of normal, apoptotic, and necrotic cells from cell mixtures.
D 2002 Elsevier Science B.V All rights reserved.
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1. Introduction
In recent years, apoptosis has attracted increasing atten-
tion. In particular, its study has led to the development of
new strategies for cancer chemotherapy [1]. One area of
intense interest is the earliest detectable, obligatory events
that precede caspase activation. Identification of such events
would contribute to a more complete understanding of the
initiation of apoptosis, and perhaps provide additional targets
for its modification and detection. Among the many differ-
ences between normal cells and those undergoing apoptosis,
one consistently observed alteration has been at the plasma
membrane [2] where cells exposed to an apoptotic initiator
show loss of structural features such as microvilli, and later,
the formation of blebs [3,4]. Downregulation of phospholi-
pid translocase and activation of nonspecific lipid scram-
blase have been reported [5,6] to catalyze rapid bi-directional
trans-bilayer movement of phospholipids with resultant
randomization of the lipid distribution. These effects destroy
the normal compositional asymmetry between the inner and
outer leaflet, causing the externalization of phosphatidylser-
ine (PS) [7], which may be revealed by the Annexin Vassay,
and used as an index for apoptosis. Various apoptosis-
inducing agents rapidly modify the transport properties of
the channels that control transmembrane ion fluxes [8],
leading to the suggestion that such flux perturbations alter
the cytoplasmic pH, activate phospholipase, and trigger the
production of ceramide, an important messenger in apoptosis
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[9]. Because of these findings, attention has been focused
upon an early and potentially obligatory role for plasma-
membrane-associated mechanisms in apoptosis.
Dielectrophoresis (DEP) is the movement of particles, for
example, cells, in inhomogeneous electrical fields based on
differences in the permittivities of the particles and their
surroundings [10–13]. The study of cellular DEP responses
as a function of the frequency of the applied electrical field
allows cell membrane capacitance and conductivity to be
deduced with single cell discrimination. It has been shown
previously that these membrane dielectric properties are
highly characteristic of, and rapidly affected by, alterations
in physiological activities and induction of pathologic states
in cells [14–20]. Such differences can be not only used for
cell characterization, but also exploited for selective cell ma-
nipulation, separation and sorting [21–24]. For this reason,
we have examined the changes in cell membrane dielectric
properties accompanying induced apoptosis to discover if
they: (1) suggest an early role of the plasma membrane in the
apoptotic cascade, and (2) if such changes could be used to
discriminate between, manipulate and separate apoptotic and
necrotic cells from normal cells, including those of the blood.
To achieve these goals, we have studied the exposure
of the human myelogenous HL-60 cell line to genistein
(GEN) as a model system. GEN, a topoisomerase and
tyrosine protein kinase inhibitor, induces apoptosis at all
phases of the HL-60 cell cycle [25,26]. Introduced into
HL-60 cell cultures at a concentration of 100 Ag/ml,
GEN induces a progressively increasing hypodiploid sub-
G1 population after 4 h, whereas cell membrane integrity
is maintained until after approximately 8 h when the cells
become necrotic [25,27]. We investigated the dielectric
properties of the cells by the DEP crossover method
[17,28] in which cells are suspended in a low-conductiv-
ity, isotonic solution and subjected to an inhomogeneous
AC electrical field that causes them to experience trans-
lational DEP forces. At low-AC field frequencies, cells
are repelled from the electrodes, whereas at high frequen-
cies, they become attracted toward electrode edges. At a
particular, intermediate crossover frequency, fcrossover, the
dielectric properties of the cell and the suspending
solution balance and the cells experience no net force.
This frequency can be easily determined by observing the
reversal of cell motion as the frequency is adjusted.
We correlated the cell dielectric properties deduced from
these measurements with DNA content and PS external-
ization as a function of time for the first 8 h after treatment,
and also with scanning electron microscopic (SEM) exami-
nations of the evolution of the cell surface morphology. The
broad-spectrum caspase inhibitor N-benzyloxycarbony-Val-
Ala-Asp(O-methyl)-fluoromethyketone (zVAD-fmk) was
used in some cultures to block the apoptotic process, which
allowed us to determine that the changes in cell dielectric
properties started early in the apoptotic process and pre-
ceded caspase activation. Our results show that DEP meth-
ods have potential for early detection and separation of
apoptotic, necrotic, and normal cells, and for the quantifi-
cation of an apoptotic population in a cell mixture.
2. Materials and methods
2.1. Cell culture and chemicals
Cells of the human myelogenous leukemia cell line HL-
60 were seeded at 1.6105 cells/ml and grown in 10 ml of
RPMI medium supplemented with 10% fetal bovine serum, 1
mM glutamine and 20 mM Hepes buffer (Gibco, Grand
Island, NY). Cell cultures were maintained in 25 cm2 vented
culture flasks (Greiner, Germany) at 37 jC under a 5% CO2/
95% air atmosphere in a humidified incubator. Cells growing
in mid-log phase were used 48 h after seeding when the cell
concentration had reachedf0.8106 cells/ml. Cell viability
was above 98% as judged by trypan blue dye exclusion.
Fresh stock solutions of GEN (G-6776, Sigma, St. Louis,
MO) and zVAD-fmk (FK-009, Enzyme Systems Products,
Livermore, CA) were prepared in DMSO at a concentration
of 5 mg/ml and 20 mM, respectively. To induce apoptosis, a
1:50 dilution of the GEN stock solution was added to the cell
culture to give a final GEN concentration of 100 Ag/ml. In
some cultures, 0.5 Al/ml of the zVAD-fmk stock solution was
added at 0.5 h before and 2.5 h after the addition of GEN, to
inhibit caspase activation. Treated cultures were maintained
alongside control samples in an incubator and aliquots of
each were withdrawn when needed for measurements.
2.2. Cell DNA analysis and the Annexin V assay
To study the changes in the cell DNA content histogram,
aliquots off106 cells were removed from control and GEN-
treated HL-60 cultures at appropriate times, centrifuged at
223g for 10 min at 4 jC, resuspended in 200 Al ice-cold
phosphate-buffered saline (PBS), fixed by the addition of 2
ml ice-cold 70% ethanol, and left for at least 1 h at 4 jC. After
fixation, cells were washed once at 223g for 10 min at 4 jC,
and resuspended in 800 Al ice-cold PBS containing 0.5%
Triton X-100 (T8787, Sigma). Then, 40 Al of 2.5 mg/ml
Rnase A (50 u/mg, Boehringer Mannheim, Germany) and
160 Al of 250 Ag/ml propidium iodide (PI) (P-4170, Sigma)
were added, and samples were incubated at 37 jC for at least
30 min. Aliquots of cells were also removed from control and
GEN-treated HL-60 cultures at appropriate times and stained
with Annexin V (APOPTESTk-FITC, cat. no.: A700, Nex-
ins Research, 4474 ND Kattendijke, The Netherlands) fol-
lowing the standard protocol from the company. The stained
samples were investigated with a Bryte HSk flow cytometer
(Bio-Rad Microscience, Hemel Hempstead, UK).
2.3. DEP crossover frequency measurements
The electrode chamber was fabricated by gluing a 15 mm
diameter1 mm thick O-ring over a glass substrate that
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supported the DEP electrode array patterned by standard
photolithography as described previously [29]. The elec-
trode array was comprised of plain parallel elements con-
nected alternately to bus lines on either side of the substrate.
The parallel elements were 12 mm long, 100 Am wide, and
separated by 100-Am gaps. To make DEP crossover fre-
quency measurements, a 3-V peak-to-peak sinusoidal signal
(HP 8116A, Hewlett-Packard, Palo Alto, CA) was applied
to the electrode array.
The cell sample was diluted in isotonic (280 mOs/kg)
8.5% (wt./wt.) sucrose plus 0.3% (wt./wt.) dextrose buffer
adjusted to the desired conductivity with RPMI. For each
experiment, 180 Al of cell suspension was pipetted into the
chamber and a cover slip was gently pressed over the center
to form a full, sealed chamber so as to prevent cells from
drifting during measurement. After cells had settled, the
electrical field was turned on. Cell movement was measured
under a Nikon Diaphot TMD inverted microscope equipped
with a CCD video camera and monitor. The crossover
frequency of randomly chosen individual cells was recorded
as the frequency at which their DEP-induced motion
changed direction. The diameter of each cell was measured
from the video monitor and calibrated against a stage
micrometer. Unless specified otherwise, the crossover fre-
quencies and diameters for 20 cells were determined in less
than 20 min for each condition studied.
For cells like HL-60 whose dielectric responses are well
described by the Single Shell model [17,30,31], the product
of the cell radius and crossover frequency, rfcrossover, is an
approximately linear function of medium conductivity,
rmed, for 0.01<rmed<0.2 S/m. The effective specific mem-
brane capacitance, Cmem=(emem)/d, and conductance,
Gmem=(rmem)/d, where d is the membrane thickness, and
emem and rmem are the membrane permittivity and conduc-
tivity, are derived from the slope and rmem axis intercept of
the linear dependency by the following relations [18,28]:
Cmem ¼
ﬃﬃﬃ
2
p
2p slope ð1Þ
and
Gmem ¼
4 interceptrmem
slope r : ð2Þ
In this study, we followed rfcrossover at a medium
conductivity of 0.056 S/m from 0 to 8 h following the
GEN treatment of cells, and measured rfcrossover as a
function of medium conductivity at 0, 1, 2, and 4 h to derive
the plasma membrane capacitance and conductance values.
2.4. Scanning electron microscopy
Cells from control and treated cultures were washed in
serum-free RPMI at 223g for 10 min at room temperature
and resuspended in 8.75% (wt./wt.) sucrose solution (280
mOs/kg) for 15 min. Cells were then centrifuged and fixed
at 37 jC in modified Karnovsky’s fixative (280 mOs/kg, pH
7.5) for at least 30 min. Cell specimens were examined
using a scanning electron microscope (Model S520, Hitachi
Denshi, Tokyo, Japan). Each specimen was first scanned to
evaluate the cell size and morphological distribution. Then
images of representative cells were recorded at a direct
magnification of 1000 to 5000 onto Polaroid films
(Polaroid, Medical Products, Cambridge, MA).
3. Results
3.1. HL-60 cells undergo apoptotic death after GEN
treatment
After adding GEN at 100 Ag/ml to HL-60 cell cultures,
cell viability remained above 90% for up to 8 h, as
determined using the trypan blue dye-exclusion method.
The results for DNA content as studied by flow cytometry
are presented in Fig. 1. Cells undergoing apoptosis can be
recognized by their diminished susceptibility to staining
with PI, resulting in a sub-G1 peak in the DNA frequency
histogram [25]. At 2 h post-GEN treatment, there was no
significant evidence of this alteration in treated cells. How-
ever, the sub-G1 population increased thereafter from
f22% of the total cells at 4 h, to f26% at 6 h, f45%
at 8 h, and f52% at 10 h. We also observed a decrease in
forward light scattering beginning at 2 h post-treatment, but
no alteration of side scattering, indicating a reduction in cell
size. These results are consistent with previous studies of the
characteristics of HL-60 cells undergoing apoptosis [25,32]
and indicate that in our cultures, GEN-induced apoptosis of
HL-60 cells proceeded in accord with published reports.
A study with the PS-binding protein Annexin V (Fig. 2)
is also consistent with earlier reports. Apoptotic cells have
significant translocation of PS to the out leaflet of cell
membrane, and will be stained by Annexin V. We found
Fig. 1. Flow cytometry study of DNA content histograms for HL-60 cells
showing cell frequency versus DNA content from 0 to 10 h after 100 Ag/ml
GEN treatment.
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that the number of Annexin V positive cells 1 h post-
treatment was not significantly different from that of control
cells, and only became so 2 h after treatment. Specifically,
Annexin V positive cells represented f5.7% of the whole
cell population, at both 0 and 1 h. This proportion increased
to 22.3% at 2 h post-treatment, 27.2% at 3 h, 47.9% at 4 h,
56.7% at 5 h, and 62.4% at 6 h.
3.2. The DEP crossover frequency increases as apoptosis
progresses and the change precedes caspase activation
Fig. 3 shows the mean and standard deviation of the
product of crossover frequency and cell radius at a medium
conductivity of 0.056 S/m as a function of time for untreated
and GEN-treated HL-60 cells. Each data point represents 20
individual cells. No significant changes occurred in the
mean dielectric properties of untreated cells as reflec-
ted by the crossover frequency measurements. This is
easi-ly rationalized because the HL-60 cultures used in this
study were harvested atf0.8106 cells/ml while they were
in log phase and at least 20 h before they began to show
any dielectric changes due to approach plateau phase
at f1.610 cells/ml. Also, for the short duration of the
experiments, cells exposed to 2% DMSO (the solvent used
to introduce GEN and zVAD-fmk to samples) did not
experience a change in the dielectric properties. For the
first hour after initiating GEN treatment, the cell radius
remained unchanged, but fcrossover increased significantly.
Thereafter, r decreased and fcrossover continued to increase
with time. This suggested that two distinct morphological
responses were occurring in response to GEN.
To determine whether either of these changes were
caspase dependent, we added 10 AM zVAD-fmk to the cell
suspension in some experiments at 30 min before and 2.5 h
after the addition of GEN. zVAD-fmk is one of the syn-
thetic, cell-permeable peptides that are non-cleavable ana-
logs of caspase substrates, and is commonly used as a
broad-spectrum caspase inhibitor [33,34]. Caspase activa-
tion is involved in early events during apoptosis and it has
been found that its inhibition blocks many features of
apoptosis including some morphological changes [34,35].
The effect of zVAD-fmk on our model is also shown in Fig.
3. In this case, the data shown are averages of 100 cells.
Interestingly, zVAD-fmk did not inhibit the initial HL-60
DEP response to GEN whereby fcrossover increased in the
first hour of treatment with cell size remaining constant.
Statistically, the probability that the responses to GEN were
the same with or without zVAD-fmk was p=0.999.
After this initial response to GEN, the cell radius of
zVAD-fmk-treated cells decreased and the product
rfcrossover fell to the same value observed for untreated
Fig. 3. Changes in cell DEP properties following apoptotic initiation with and without the presence of zVAD-fmk. Untreated (Control) cells and cells treated
with 2% DMSO are also indicated. The bars show the standard deviation.
Fig. 2. Flow cytometry results of the Annexin V assay on HL-60 cells from
0 to 6 h after 100 Ag/ml GEN treatment. A significant Annexin V-positive
subpopulation relative to 0 h begins to appear at 2 h.
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cells, and remained at that value for the duration of the
experiment. There was no indication in the DNA or
Annexin V measurements that any response to GEN had
occurred with zVAD-fmk present. Finally, the probability
that the GEN-treated groups of cells had the same DEP
response as the GEN-untreated groups at 1 h was p<0.001.
3.3. The dielectric properties of necrotic cells are
significantly different from those of normal or apoptotic
cells
While most of the GEN-treated cells during our crossover
frequency measurements remained indistinguishable from
control cells under light microscopy, a small subpopulation
developed atypically large radii, exhibited roughened surfa-
ces, and showed gross signs of active membrane blebbing
compared with control cells. This subpopulation stained
positively with trypan blue, showing that cell membrane
barrier function had been compromised. The proportion of
cells in this subpopulation increased over time from zero at 2
h post-GEN treatment, to approximately 5% of the total cell
population at 4 h, and nearly 10% at 6 h. Because these cells
were trypan blue-positive, it is considered that they are
necrotic cells. At a medium conductivity of 0.056 S/m, the
crossover frequencies for control cells were between f80
andf130 kHz, and for cells undergoing apoptosis between
f130 and f200 kHz. In contrast, crossover frequencies
for these putatively necrotic cells were in the megahertz
range with some above 10 MHz. Fig. 4 shows data of
fcrossover versus time for necrotic, apoptotic and normal
cultured cells in the form of a log plot. Each data point for
the necrotic cells is an average of five cells. The significantly
higher fcrossover for necrotic cells can be explained by DEP
theory if we assume that the necrotic cells had lost a
considerable proportion of their internal ions to the low-
conductivity-suspending medium [11]. This assumption is
consistent with the indication from trypan blue staining that
cell membrane barrier function had been compromised.
3.4. Alterations in cell membrane capacitance and con-
ductance during apoptosis progression
Membrane capacitance is a measure of the area of the
membrane that acts as a barrier toward, and can accumulate,
ionic charges in the suspending medium in response to the
applied electrical field. Membrane conductance, on the other
hand, reflects the net transport of ionic species across the
membrane through pores, ion channels, and defects under the
influence of the applied field. To quantify these properties,
we measured the individual crossover frequency and radius
for 20 HL-60 cells at medium conductivities of 0.015, 0.025,
0.035, 0.045, and 0.055 S/m, at 0, 1, 2, and 4 h after GEN
was introduced. Fig. 5 shows the averaged rfcrossover values
versus medium conductivity rmed. A least-squares linear fit
was performed to provide the slope and ordinate intercept.
The specific cell membrane capacitance and conductance
were derived using Eqs. (1) and (2). The results are given in
Table 1, which demonstrate that apparent cell-specific mem-
brane capacitance decreased as apoptosis progressed.
Alterations in membrane conductance occurred later than
the changes seen in membrane capacitance (see Table 1).
The 60% increase at 4 h might result from membrane
Fig. 4. Changes in cell crossover frequencies following apoptotic initiation. The DEP crossover frequencies for necrotic cells were greatly different from
normal or apoptotic cells.
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alterations such as looser packing of phospholipids [36] and
increased field-dependent ion migration through ion chan-
nels during apoptosis rather than the permeabilization of the
cells. It is known that cells undergoing apoptosis maintain
the barrier function of their plasma membranes for several
hours after initiating nuclear damage [25,37]. Membrane
permeabilization is considered a relatively late-stage event
of apoptosis and results in a huge increase in membrane
conductance [11] as confirmed in Fig. 4 for necrotic cells.
Previous studies have shown that differences in the
specific plasma membrane capacitance of different cells
appear to be dominated by membrane morphological con-
figurations so that a lower limit for its value is expected to
correspond to a smooth membrane that is free of surface
morphological features [18,38–41]. Therefore, we would
expect cell membrane capacitance not to fall below this
plateau as apoptosis progresses. Membrane conductance, on
the other hand, can conceivably increase independently until
the membrane barrier function breaks down completely.
3.5. SEM
Specific membrane capacitance is defined as the capaci-
tance per unit area of the cytoplasmic membrane. As already
indicated, previous studies [38,42,43,47] have demonstrated
that the cell-specific membrane capacitance varies very little
with changes in membrane composition and largely depends
on contribution associated with cell plasma membrane sur-
face morphology, such as microvilli, ruffles, folds, etc.
These surface features increase the net surface area of the
cell membrane and thereby increase Cmem, the capacitance
per unit area of the cell surface [11,18,38]. It follows that the
specific membrane capacitance, to a significant degree,
reflects the complexity of the cell surface morphology.
To determine whether the evolution of the cell membrane
morphology during induced apoptosis could account for the
observed dielectric responses following GEN treatment,
SEM was used to examine the cell surfaces. Fig. 6 depicts
SEM micrographs of representative cells fixed in isotonic
medium at 0, 1, 2, and 4 h after adding GEN. The surfaces
of control cells were covered with abundant microvilli (Fig.
6A). As early as 1 h after the introduction of GEN, blebs
appeared on the surface of approximately 5% of cells (Fig.
6B). This phenomenon was progressive and blebs were
evident on the surfaces of as many as 25% of the cells at
2 h. It was associated with increases in smooth areas of the
surface (Fig. 6C) suggesting that microvilli and other
membrane features were lost to the blebs. By 4 h, most of
the cell surfaces were predominantly smooth with few
Table 1
Changes in dielectric properties of cell membrane for normal and apoptotic
HL-60 cells treated with GEN
Cmem (mF/m
2) Gmem (S/m
2)
Untreated cells 17.5F0.8 (2.5F1.1)103
GEN, 0 h 17.6F0.9 (2.5F1.0)103
GEN, 1 h 15.9F0.7 (2.4F1.1)103
GEN, 2 h 13.1F0.8 (2.5F1.2)103
GEN, 4 h 9.1F0.5 (4.2F1.0)103
Fig. 5. DEP characteristics of HL-60 cells expressed as rfcrossover versus the suspending medium conductivity rmed following treatment by GEN at 100 Ag/ml.
Straight lines show least-square linear fits to the data.
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microvilli (Fig. 6D). The loss of surface area due to
decreasing morphological complexity paralleled and was
completely consistent with the observed decrease in mem-
brane capacitance during the progression of apoptosis.
4. Discussion
Our results show for the first time that membrane
dielectric properties clearly reflect cells undergoing apopto-
sis. As a result, cellular DEP responses clearly delineate
apoptotic from normal and necrotic cells of the same lineage
under the same incubation conditions. In prior studies, we
and others have demonstrated that such measurements by
various DEP methods allow progressive alterations of both a
physiologic and a pathologic nature to be followed, and that
the dielectric changes seen are related to alterations in the
cell plasma membranes [14–19,38,39]. Alterations in cel-
lular DEP characteristics appear to be very sensitive meas-
ures of the cellular ‘‘dielectric-phenotype’’, a function of
membrane capacitance and conductivity, cell size, and intra-
cellular components. Thus, well-defined differences have
been identified in lymphocytes during their mitotic cycle
[19,39], and in tumor cells undergoing terminal cell division
and during retro-transformation [15,18,38]. We believe that
it is not coincidental that such alterations also occur during
the apoptotic process.
It is noteworthy that the results reported here describe
significant alterations in DEP crossover frequency and
membrane capacitance as early as 1 h after GEN treatment,
and precede caspase activation. It appears therefore, that
they preceded or were closely associated in time with some
of the earliest described events of this experimental model.
For example, while externalization of PS is considered an
early event during apoptosis [37], we detected DEP changes
at least an hour before we could detect an increase in PS or a
sub-diploid cell population. These results indicate that it
might be possible to correlate changes in cell dielectric
properties with very early stages of apoptosis and use cell
DEP characteristics as early and sensitive prognostic
markers for apoptosis. We illustrate this point in Fig. 7,
where results from Figs. 1–3 are compared for sensitivity.
This figure shows that when compared with the percentage
of cells in the sub-G1 peak in the DNA histogram, or the
number of Annexin V-positive cells in a culture, the DEP
crossover method is much more sensitive. (F-tests for these
sensitivity plots revealed that the statistical confidence
levels that the sensitivity characteristics are different were
>99.99% and >99.999%, for DEP vs. Annexin and DEP vs.
DNA fragmentation, respectively.)
While the experiments using zVAD-fmk demonstrate
clearly that caspase inhibition cause cells to re-establish
normal behavior after 1 h, DEP can apparently detect a
reversible event that precedes caspase involvement.
Fig. 6. SEM pictures of HL-60 cells at magnification 2500 at 0 (A), 1 (B), 2 (C), and 4 h (D) following GEN treatment reveal the evolution of changes in cell
membrane morphology as apoptosis progressed.
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The alterations described in this paper accompanying
induced apoptosis were not limited to HL-60 cells treated
with GEN. Quantitatively similar results in terms of DEP
crossover frequencies and morphological alterations were
obtained when HL-60 cells were treated with campothecin
(data not shown). The campothecin regimen differed some-
what in the timing and synchronicity of events as would be
predicted from the differential effect that this agent has on
different stages of the cell cycle [7,26]. Preliminary studies
on Jurkat cells treated with GEN also demonstrated the
sequence of events described in this paper for HL-60 cells
(data not shown). Through the application of SEM, we have
also demonstrated that a striking alteration and simplifica-
tion of the cell surface paralleled the observed dielectric
alterations.
Morphological simplification of the cell surface has been
described previously as an early event in the apoptotic
process [3,4,44]. However, to date, no mechanism has been
identified to clearly explain this phenomenon. Such mor-
phological changes alone can account for the dielectric
alterations demonstrated here, with a possible minor con-
tribution from membrane compositional modifications.
Also, at the plasma membrane level, it has been suggested
that drastic, very early alterations in the function of ion
channels, and especially those related to chloride and
potassium homeostasis, are crucial to the subsequent events
in the apoptotic sequence [8]. Clearly, it would be of interest
to correlate such specific processes with the changes we
have observed here. Our findings suggest that further
investigation is needed of the plasma membrane as a
possible site for early and obligatory participation in apop-
tosis.
The dielectric changes observed during induced apoptosis
have a potentially much wider application than studying
cellular structural correlations with signaling events. Cells
possessing dissimilar dielectric properties can be selectively
manipulated by application of an appropriate electrical field
distribution, frequency, and suspending medium conditions
[12,21,22,24,45–47]. We have shown that such manipula-
tions do not alter cell viability [48]. Therefore, in addition to
further defining cell phenotype, DEP offers considerable
potential for cell separation and purification applications.
The dielectric characterization and manipulation of biolog-
ical cells are currently attracting increasing interest. For
example, in the past few years, we and others have reported
a number of cell separations, including human cancer cells
from normal blood cells [21,49,50], viable cells from non-
viable ones [46], and the purification of CD34+ cells from
blood [45] and from tumor cells [12], as well as a number of
blood cell differential analyses [24]. The changes observed
here during cell apoptosis are large enough to permit the
separation of apoptotic from normal cells by high discrim-
ination methods such as dielectrophoretic field flow fractio-
nation (DEP-FFF) [12]. Although the easier method of DEP-
trapping lacks sufficient discrimination for that separation, it
could certainly separate normal from necrotic cells given the
large dielectric differences in that case [51]. It follows that
DEP methods appear to be applicable to the detection of
apoptosis and necrosis and to the separation of apoptotic and
necrotic cells from normal cells. This is important, for
example, for the detection and quantification of apoptotic
cells in cell cultures (for drug sensitivity testing), in the blood
of patients before and during cancer treatment, and for other
diagnostic and prognostic purposes.
Fig. 7. Use of the change in DEP crossover frequency to detect apoptosis is compared with DNA histogram and Annexin V staining methods. These results
show that the DEP crossover method is the most sensitive, especially at the early time points.
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